Skin toxicity of enfortumab vedotin: Proposal of a specific management algorithm

Affiliations

• ¹ Dermatology Department, AP-HP, Henri Mondor Hospital, Univ Paris Est Créteil EpiDermE, Créteil, France.
• ² Reference Center for Toxic Bullous Diseases and Severe Drug Reactions TOXIBUL, Créteil, France.
• ³ Dermatology for Cancer Patients EADV Task Force, Toulouse, France.
• ⁴ Department of Dermatology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
• ⁵ Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
• ⁶ Dermatology Department, Hospital del Mar, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Universitat Pompeu Fabra, Barcelona, Spain.
• ⁷ Dermatology Unit, Department of Medicine, Gustave Roussy Cancer Campus, Villejuif, France.
• ⁸ Oncology Department, Institut Universitaire du Cancer, Toulouse Oncopole, Toulouse, France.
• ⁹ Dermatology Department, Helsinki University Hospital, Helsinki, Finland.
• ¹⁰ Dermatology Department, Hospital 12 de Octubre, Madrid, Spain.
• ¹¹ Oncology Department, AP-HP, Henri Mondor Hospital, Créteil, France.
• ¹² Univ Paris Est Creteil, TRePCa, Créteil, France.
• ¹³ Department of Medical Oncology, University Hospital of Heraklion, Heraklion, Crete, Greece.
• ¹⁴ Department of Pathology, Institut Universitaire du Cancer, Toulouse Oncopole, Toulouse, France.
• ¹⁵ Department of Dermatology and Venereology, University Hospital of Heraklion, Crete, Greece.